“Latest Stem Cells News”

Stem Cell Therapy for Multiple Sclerosis- Giving Life Back

Multiple Sclerosis had taken many things away from Jason Upshaw- his job at the Sheriff’s department, his ability to play with his kids, as well as his ability to walk. Jason had given up hope . Luckily for Jason, he found an article about Preston Walker, another law enforcement officer in Texas with MS. Preston Walker had gone to Costa Rica for a new stem cell treatment and therapy using Adult Stem Cells and had reported tremendous improvements.

Jason, 36, of Erath County, Texas contacted Preston Walker who gave the stem cell therapy a glowing review.  Jason promptly contacted the stem cell treatment company in Costa Rica and arranged to go there for treatment.

In June, 2008, Jason went to Costa Rica with his mother to receive the Adult Stem Cells that would turn his life around.

Multiple Sclerosis Symptoms Before the Stem Cell Treatment

• numbness and tingling on his right side
• balance issues- had to use a scooter to mover around outside
• poor coordination
• severe heat sensitivity

MS Symptoms After the Stem Cell Therapy

• Not Applicable (NA)
• NA
• NA

Jason no longer has any symptoms of Multiple Sclerosis and he has stopped seeing his neurologist.  He is also back to playing baseball in the backyard with his kids.

Incoming search terms:

Stem Cell Research Study Reveals Stroke Patients Helped by Own Stem Cells

A new stem cell research study/trial recently completed shows that implanting a person’s own Adult Stem Cells helps stroke patients overcome partial paralysis. Dr. Kameshwar Prasad of the All India Institute of Medical Sciences (AIIMS) will present his stem cell study at the European Stroke Research Conference in May, 2009.

Stroke Victims Own Adult Stem Cells Used

In the stem cell study that took place in New Delhi, India, 12 stroke victims had their own stem cells implanted within 1 month after a stroke. Also, 3 stroke patients were used as a control group and were not given any stem cells.

Process of Stem Cells for Stroke

1. Adult Stem Cells extracted from patient’s bone marrow
2. Stem Cells are then purified
3. Patient’s own stem cells are then reintroduced intravenously into the antecubital vein (in the forearms, near the elbow)
4. Stem Cells migrate to area of injury (in this case- the brain)
5. Adult Stem Cells enhance repair process and reduce brain damage

Incoming search terms:

Roland "Bud" Henrich, 61, was the first stroke patient to be enrolled in a Phase I trial using his own stem cells.

For the first time in the United States, a stroke patient has been intravenously injected with his own bone marrow stem cells as part of a research trial at The University of Texas Medical School at Houston.
Sean Savitz, M.D., assistant professor of neurology at The University of Texas Medical School at Houston, leads a first-of-its-kind bone marrow stem cell therapy study for stroke patients.

Roland “Bud” Henrich, 61, was transferred to Memorial Hermann – Texas Medical Center on March 25 after suffering a stroke while working on his farm in Liberty. He arrived too late to receive tissue plasminogen activator (tPA), the only treatment for ischemic strokes. He became the first patient in the trial.

The Phase I safety trial, funded with a pilot grant from The National Institutes of Health and support from the Notsew Orm Sands Foundation, will enroll nine more patients who have suffered a stroke and can be treated with the stem cell procedure within 24 to 72 hours of initial symptoms.

Incoming search terms:

A substantial donation made by Ferrari of 320.000 euros will aid in the development of activities ongoing at the Woman and Infant’s Research Laboratory at the University Hospital in Modena. The presentation of the laboratory, located on the 7th floor of the hospital, and recently restructured, was presented yesterday to Ferrari President Luca di Montezemolo, regional Health councilor Giovanni Bissoni, Vice-Chancellor of the University of Modena and Reggio Emilia Aldo Tomasi, Mayor Pighi, President of the Province Sabattini, and the heads of the hospital.

Incoming search terms:

JAMA

Adult Stem Cell Research Shows that Diabetes Type 1 Can Be Helped

In a Stem Cell research study that is being published today in the Journal of American Medical Association (JAMA), Adult Stem Cells have been used to help patients with Diabetes Type 1.

20 of 23 Patients Helped With Their Own Adult Stem Cells

23 patients who were newly diagnosed (within 6 weeks) with Diabetes Type 1 were first given chemotherapy to dampen their immune system, then they were given their own stem cells taken from their blood.

Of those 23 patients, 20 “reduced or ended dependence on insulin as their bodies took over production of the hormone.” Of those 20 patients, 12 of them were off insulin for a long period of time, while 8 relapsed and went back to taking small doses of insulin.

According to the stem cell abstract:

Conclusion After a mean follow-up of 29.8 months following autologous nonmyeloablative HSCT in patients with newly diagnosed type 1 DM, C-peptide levels increased significantly and the majority of patients achieved insulin independence with good glycemic control.

Incoming search terms:

Mental retardation, altered facial characteristics, and heart problems are all problems suffered by children affected by Costello syndrome, a genetic disease that is being studied by researchers in Milan at the Italian Foundation for Cancer Research (FIRC) Institute of molecular oncology (IFOM) using the zebrafish as a model.

The cause of the disease – explained the scientists in the January issue of ‘Disease Models & Mechanisms’ monthly magazine – is a mutation of the Ras gene, the same alteration observed in 20pct of tumors. One out of every five cases of cancer and the rare genetic disease have a common thread.

The credit for the discovery also goes to the zebrafish, an important animal among the most popular in laboratories worldwide, since it is versatile, transparent, and mainly, genetically similar to humans. The mutation of the Ras gene responsible for the Costello syndrome – according to a study supported by the Italian Association for Cancer Research (AIRC) – is manifested in the patient’s germ cells.

Incoming search terms: